$RLAY·8-K

Relay Therapeutics, Inc. · Feb 26, 4:10 PM ET

Compare

Relay Therapeutics, Inc. 8-K

Research Summary

AI-generated summary

Updated

Relay Therapeutics Reports Q4 and Full-Year 2025 Financial Results

What Happened
Relay Therapeutics, Inc. announced its financial results for the quarter and full year ended December 31, 2025 in a press release dated February 26, 2026. The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8-K (Item 2.02: Results of Operations and Financial Condition). The Form 8-K notes the information is furnished (not “filed”) under the Securities Exchange Act and therefore is not subject to Section 18 liability.

Key Details

  • Press release announcing quarterly and full-year results dated February 26, 2026.
  • Financial results cover the quarter and year ended December 31, 2025.
  • Press release furnished as Exhibit 99.1 to the Form 8-K.
  • Filing explicitly states the information is furnished, not filed, under the Exchange Act.

Why It Matters
This filing signals Relay’s official release of its latest earnings and revenue-related information; investors should read the furnished press release and any subsequent SEC filings for the specific financial metrics (revenue, net income/loss, cash runway, guidance) that drive stock valuation. The “furnished, not filed” status is a technical legal note about liability and does not change the substance of the financial information — but investors looking for formal, legally filed disclosures should also monitor the company’s 10-K/10-Q submissions.

Loading document...